ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy

Targeting nuclear ErbB-2 could be a new and effective strategy to manage ErbB-2-positive breast cancer.

 Endcocr Rel Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.